Profound Medical announces PRO FAMILIA hospital completes 500th Sonalleve procedure

Profound Medical Corp.

PRO FAMILIA Specialist Hospital in Rzeszów, Poland performed its 500th Sonalleve MRI-guided focused ultrasound procedure.
Sonalleve provides non-surgical treatment for uterine fibroids and adenomyosis, with no incisions, no blood loss, and no overnight stay.
Over 4,000 women treated globally with 10 Sonalleve devices in Europe, China, and Southeast Asia.
CEO Arun Menawat notes Sonalleve international growth while U.S. focus remains on TULSA-PRO commercialization.
Approximately $10 million in research grants from European and Canadian organizations over five years for Sonalleve studies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.